Arca
Skip to content
Tools
Tools

PharmaCyte Biotech, Inc.

3 private offerings reported to the SEC on Form D since 2016, $78.0M sold in all. Biotech, Nevada.

  • Form D offerings: 3
  • Reported sold: $78.0M
  • Newest: Sep 4, 2025
  • FDA records: Company page

Every Form D offering

Newest first; an amended notice updates the amount sold. Each filing opens on EDGAR.
Sep 4, 2025โ€”$7.0M$7.0MPharmaCyte Biotech, Inc.Biotech ยท NevadaNot amended0001683168-25-006676
Sep 1, 2021โ€”$70.0M$70.0MPharmaCyte Biotech, Inc.Biotech ยท CaliforniaNot amended0001683168-21-004022
Jan 19, 2016โ€”$1.0M$3.1MPharmaCyte Biotech, Inc.Pharma ยท MarylandNot amended0001019687-16-004862

SEC Profile

From the company's EDGAR record
Ticker
PMCB
Business address
Las Vegas, NV
Incorporated in
Nevada
SEC industry
Biological Products, (No Diagnostic Substances)
Former names
Nuvilex, Inc.; Efoodsafety Com Inc
All SEC filings
CIK 1157075 on EDGAR

A Form D reports the amount offered and sold so far in a private offering, not who invested or at what valuation. Shares issued in a merger are left out. The profile is read from EDGAR daily. SEC Form D data sets and EDGAR

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.